Management strategies in antithrombotic therapy /

Management strategies in antithrombotic therapy /

42

Detalhes bibliográficos
Main Authors:	375852 Askari, Arman, Messerli, Adrian W.
Formato:
Idioma:	eng
Publicado em:	Chichester, West Sussex : John Wiley and Sons, 2007
Assuntos:	Thrombolytic therapy Thrombosis Fibrinolytic agents

Registos relacionados

Antithrombotic drugs in thrombosis models /
Por: 403044 Hladovec, Josef
Publicado em: (1989)

Thrombin structure and function : why thrombin is the primary target for antithrombotics /
Por: Fenton, John W.

Exploring the fibrinolytic potential of marine Actinoalloteichus caeruleus isolated from Bay of Bengal coast
Por: Kothari Neeti Suresh, et al.
Publicado em: (2025-03-01)

Initial Results of Oral Thrombolytic Agent Clinical Application
Por: Pavel Madonov, et al.
Publicado em: (2018-07-01)

Fibrinolytic Therapy in Thrombosis of Mechanical Valves: Outcomes and Complications
Por: Ali Nasri Nasrabadi, et al.
Publicado em: (2023-09-01)

Research progress on sources and production methods of natural fibrinolytic enzymes
Por: PENG Cuiying, WANG Panpan, DENG Xiongwei, XIE Xiaomei, WENG Meizhi
Publicado em: (2024-02-01)

Antithrombotic properties of policosanol rice (Oryza sativa L.) bran in modulating blood platelet properties in in vitro, ex-vivo and in vivo model
Por: Wong, Wai Teng
Publicado em: (2020)

Identification and characterization of fibrinolytic enzyme producing bacteria isolated from shrimp paste /
Por: Abir Mabruk M.Benashur, 1982-, et al.
Publicado em: (2011)

Identification and characterization of fibrinolytic enzyme producing bacteria isolated from shrimp paste [electronic resource] /
Por: Abir Mabruk M.Benashur, 1982-
Publicado em: (2011)

Endovascular Treatment of Cerebral Venous Sinus Thrombosis
Por: J Gordon Millichap
Publicado em: (2013-12-01)

A Prospective Multicenter Study Evaluating Bleeding Risk after Endoscopic Ultrasound-Guided Fine Needle Aspiration in Patients Prescribed Antithrombotic Agents
Por: Kazumichi Kawakubo, et al.
Publicado em: (2018-05-01)

Protection of Tight Junctional Complexes between hCMEC/D3 Cells by Deep-Sea Fibrinolytic Compound FGFC1
Por: Xiaozhen Diao, et al.
Publicado em: (2024-07-01)

Berberine Targets PKM2 to Activate the t-PA-Induced Fibrinolytic System and Improves Thrombosis
Por: Zeqi Sun, et al.
Publicado em: (2024-09-01)

THROMBOLYTIC THERAPY IN PATIENTS WITH MYOCARDIAL INFARCTION
Por: G. P. Ishmurzin, et al.
Publicado em: (2010-12-01)

Successful Treatment of Multiple Arterial Thrombosis in Premature Infant: Clinical Case
Por: Ekaterina S. Matros, et al.
Publicado em: (2024-05-01)

Molecular cloning and characterization of a new fibrinolytic enzyme from acinetobacter baumannII TU04 /
Por: Renuka P. Krishnan, 1987-, author, et al.
Publicado em: (2016)

Molecular cloning and characterization of a new fibrinolytic enzyme from acinetobacter baumannII TU04 /
Por: Renuka P. Krishnan, 1987-, author, et al.
Publicado em: (2016)

Enzymatic analysis of native and recombinant fibrinolytic enzyme from Bacillus Cereus 13BN isolated from Belacan /
Por: Zarita Zakaria, 1978-, author, et al.
Publicado em: (2016)

Enzymatic analysis of native and recombinant fibrinolytic enzyme from Bacillus Cereus 13BN isolated from Belacan /
Por: Zarita Zakaria, 1978-, author, et al.
Publicado em: (2016)

The comparison of streptokinase, an old agent, versus reteplase for the re-tunnellisation of blocked cuffed haemodialysis catheter
Por: Saroukhani Abbas, et al.
Publicado em: (2024-01-01)

Analysis of factors influencing the early efficiency of systemic thrombolytic therapy for ischemic stroke
Por: Elena Vladimirovna Prazdnichkova, et al.
Publicado em: (2013-11-01)

Surgery compared to fibrinolytic therapy for symptomatic left-sided prosthetic heart valve thrombosis (SAFE-PVT): Rationale and design of a randomized controlled trial
Por: Niveditha Devasenapathy, et al.
Publicado em: (2024-05-01)

Comparison of Intracranial Hemorrhage and Clinical Outcomes Among Patients Undergoing Mechanical Thrombectomy with and without Thrombolytic Therapy
Por: Zulfikar Memis, et al.
Publicado em: (2024-09-01)

Reperfusion therapy of ischemic stroke
Por: L. B. Novikova, et al.
Publicado em: (2020-03-01)

EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION
Por: P. G. Kesov, et al.
Publicado em: (2015-09-01)

The II International Conference "Interdisciplinary Problems of Thrombosis, Hemostasis and Antithrombotic Therapy"
Por: article Editorial
Publicado em: (2022-11-01)

ANTITHROMBOTIC THERAPY IN PATIENTS WITH METABOLIC SYNDROME AFTER ABDOMINAL DELIVERY
Por: A. V. Khromylev, et al.
Publicado em: (2016-10-01)

Factors influencing the efficiency and safety of systemic thrombolysis in patients with ischemic stroke
Por: N. A. Shamalov, et al.
Publicado em: (2014-10-01)

Thrombolytic therapy in patients with ischemic stroke in the vertebrobasilar system
Por: K V Anisimov, et al.
Publicado em: (2012-09-01)

Experience with the use of combination antithrombotic therapy in a patient with acute coronary syndrome and underlying severe coronavirus infection
Por: D. A. Kurenkov, et al.
Publicado em: (2022-06-01)

TO THE QUESTION OF EFFICACY AND SAFETY OF FORTELYZIN® THERAPY ON ACUTE CORONARY SYNDROME: TWO CLINICAL CASES
Por: D. S. Yunevich, et al.
Publicado em: (2018-03-01)

The first experience with thrombolytic therapy for cerebral infarction in the Russian Federation after the use of idarucizumab
Por: E. V. Pudov, et al.
Publicado em: (2020-02-01)

Aspects of the use of antithrombotic therapy in vascular neurology: A review
Por: Olga V. Karpova, et al.
Publicado em: (2024-05-01)

Optimal antithrombotic therapy after transcatheter aortic valve replacement: a comprehensive review
Por: Nguyen Van Thai Thanh, et al.
Publicado em: (2025-03-01)

Acute Heart Failure After Myocardial Infarction
Por: Amra Macić-Džanković, et al.
Publicado em: (2007-02-01)

Clinical effectiveness of thrombolytic therapy with alteplase and double antiplatelet therapy in acute myocardial infarction
Por: D. N. Kuznetsov, et al.
Publicado em: (2011-12-01)

COVID-19: hemostatic parameters and specifics of antithrombotic treatment
Por: I. S. Yavelov, et al.
Publicado em: (2020-07-01)

THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL INFARCTION
Por: D. P. Sementsov
Publicado em: (2015-12-01)

Efficacy of medical thoracoscopy combined with fibrinolytic therapy in the treatment of complicated parapneumonic effusions and empyema
Por: Feng-Fu Zhan, et al.
Publicado em: (2025-02-01)

COMBINED INTERVENING THERAPY OF BRAIN INFARCTION IN THE MIDDLE CEREBRAL ARTERY CIRCULATION
Por: V. A. Saskin, et al.
Publicado em: (2017-12-01)